Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04055051 · ClinicalTrials.gov registry record
ATHN 11: Liver Transplantation Outcomes Study
A clinical trial, sponsored by American Thrombosis and Hemostasis Network.
- Completed
- Registry status
- 86
- Enrollment target
NCT04055051 is a clinical trial that has completed, run by American Thrombosis and Hemostasis Network. The registered enrollment target is 86 participants.
The verdict
NCT04055051 has completed, sponsored by American Thrombosis and Hemostasis Network.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
This study is designed as a multi-center, observational cohort study of participants with hemophilia A and B who have and have not undergone liver transplantation. Participants will be asked to complete health related quality of life questionnaires and provide medical history.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2020-06-18 |
| Est. Completion | 2022-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04055051
The ClinicalTrials.gov registry entry for NCT04055051 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Thrombosis and Hemostasis Network, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04055051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04055051 about?
NCT04055051 is a clinical study titled "ATHN 11: Liver Transplantation Outcomes Study". This study is designed as a multi-center, observational cohort study of participants with hemophilia A and B who have and have not undergone liver transplantation. Participants will be asked to complete health related quality of life questionnaires and provide medical history.
What is the current status of trial NCT04055051?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2020-06-18. Estimated completion is 2022-12-01.
Who is sponsoring clinical trial NCT04055051?
This trial is sponsored by American Thrombosis and Hemostasis Network, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.